4//SEC Filing
Harshbarger Benjamin 4
Accession 0001104659-17-057897
CIK 0000827809other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:46 PM ET
Size
9.4 KB
Accession
0001104659-17-057897
Insider Transaction Report
Form 4
Harshbarger Benjamin
General Counsel and Secretary
Transactions
- Exercise/Conversion
Restricted Stock Units
2017-09-17−337→ 336 total→ Common Shares (337 underlying) - Exercise/Conversion
Common Shares
2017-09-17+337→ 1,782 total - Tax Payment
Common Shares
2017-09-17$7.08/sh−109$772→ 1,673 total
Footnotes (4)
- [F1]Reflects a one-for-five share consolidation of the common shares of the Issuer effective December 16, 2016.
- [F2]Each restricted stock unit represents a contingent right to receive one common share.
- [F3]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person.
- [F4]33.33% of the grant vested on September 17, 2017. Subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer, the remaining 33.33% of the units will vest on September 17, 2018.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001653133
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:46 PM ET
- Size
- 9.4 KB